Showing 1131-1140 of 1308 results for "".
- Neurotech Appoints Beth Marsh as Chief Commercial Officerhttps://modernod.com/news/neurotech-appoints-beth-marsh-as-chief-commercial-officer/2482746/Neurotech Pharmaceuticals announced the appointment of Beth Marsh as Chief Commercial Officer, effective April 28, 2025. In this role, Ms. Marsh will lead the commercial organization, including preparing for the US launch of Encelto (revakinagene taroretcel-lwey), the first and onl
- Maura Sweeney Appointed Chief Operating Officer at Lighthouse Guildhttps://modernod.com/news/maura-sweeney-appointed-chief-operating-officer-at-lighthouse-guild-1/2482720/Lighthouse Guild announces the appointment of Maura Sweeney as Chief Operating Officer, effective April 1, 2025. Ms. Sweeney has been a vital part of Lighthouse Guild since 2010, most recently serving as Chief Program and Services Officer. A seasoned health care professional, she brings
- Prevent Blindness Receives Legacy Donation of $9.7 Million, Largest in Historyhttps://modernod.com/news/prevent-blindness-receives-legacy-donation-97-million-largest-in-history/2482622/Prevent Blindness announced it has received a donation of $9.7 million from the Estate of Pamela Behrens, a Florida resident and previous donor. Founded in 1908, this is the largest donation the organization has ever received. Ms. Behrens made the donation in honor of her late hus
- Nicole Skibinski Appointed Chief Executive Officer of Fluorescene Mediahttps://modernod.com/news/nicole-skibinski-appointed-chief-executive-officer-of-fluorescene-media/2482562/Nicole Skibinski was appointed Chief Executive Officer of Fluorescene Media, which aims to help optometry professionals connect, learn, and thrive. Ms. Skibinski has more than 20 years of leadership in the eye care and health care industries, with experience in
- Neuro-Optometric Rehabilitation Association Appoints Barbara Barclay as New Executive Directorhttps://modernod.com/news/neuro-optometric-rehabilitation-association-appoints-barbara-barclay-as-new-executive-director/2482455/The Neuro-Optometric Rehabilitation Association, International (NORA), has announced the appointment of Barbara Barclay as its new executive director, effective October 1. Ms. Barclay, an expert in eye-tracking technology and health tech, brings more than 30 years of leadership experience, i
- Abigail Markward Named Executive Director of ASOAhttps://modernod.com/news/abigail-markward-named-executive-director-of-asoa/2482399/The American Society of Ophthalmic Administrators (ASOA) has announced the appointment of Abigail Markward, MBA, as its new executive director, effective immediately. In addition to this new role, Ms. Markward will continue her responsibilities as executive director of the ASCRS Foundation, a pos
- Karen Petrou Appointed Board Chair of the Foundation Fighting Blindnesshttps://modernod.com/news/karen-petrou-appointed-board-chair-of-the-foundation-fighting-blindness/2482334/The Foundation Fighting Blindness announced the appointment of Karen Petrou as Board Chair, effective July 1, 2024. Petrou succeeds David Brint, who is retiring after 8 years of service. Ms. Petrou’s becomes the third person to hold the position in the Foundation&rs
- Lucentis Biosimilar Receives Marketing Authorization from the Saudi Food & Drug Authorityhttps://modernod.com/news/lucentis-biosimilar-receives-marketing-authorization-from-the-saudi-food-drug-authority/2482156/Formycon AG and MS Pharma announced that Ravegza (FYB201), a biosimilar to Lucentis (ranibizumab), has received marketing authorization from the Saudi Food & Drug Authority. Ravegza is approved in Saudi Arabia for the treatment of patients with wet age-related macular
- Opthea Names New Clinical and Regulatory Leadership Membershttps://modernod.com/news/opthea-names-new-clinical-and-regulatory-leadership-members/2482091/Opthea announced the appointment of Julie Clark, MD, MS, as Senior Vice President (SVP), Clinical Development; and Fang Li, PhD, RAC, as SVP, Regulatory Affairs, effective February 1, 2024. Dr. Clark and Dr. Li will report to Opthea Chief Executive Officer Frederic Guerard, PharmD,
- Ashley Magargee Named CEO of Genentechhttps://modernod.com/news/genentech-names-ashley-magargee-as-ceo/2482008/Ashley Magargee has been appointed Chief Executive Officer (CEO) of Genentech, effective January 1, 2024. In addition to her role as Head of US Commercial Portfolio, Ms. Magargee has been serving as ad interim CEO since the departure of Alexander Hardy on November 1, 2023. She will repo